CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $16,000 | +433.3% | 1,300 | +584.2% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 190 | -42.9% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 333 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -89.2% | 333 | -87.6% | 0.00% | – |
| Q4 2018 | $37,000 | +27.6% | 2,694 | +26.8% | 0.00% | – |
| Q3 2018 | $29,000 | -37.0% | 2,125 | -24.9% | 0.00% | – |
| Q2 2018 | $46,000 | 0.0% | 2,830 | 0.0% | 0.00% | – |
| Q1 2018 | $46,000 | +64.3% | 2,830 | +83.6% | 0.00% | – |
| Q4 2017 | $28,000 | +75.0% | 1,541 | +86.1% | 0.00% | – |
| Q3 2017 | $16,000 | +700.0% | 828 | +342.8% | 0.00% | – |
| Q2 2017 | $2,000 | -77.8% | 187 | -76.2% | 0.00% | – |
| Q1 2017 | $9,000 | -30.8% | 787 | -55.0% | 0.00% | – |
| Q4 2016 | $13,000 | – | 1,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,951,077 | $178,226,000 | 9.95% |
| Parallel Advisors, LLC | 3,769,455 | $96,649,000 | 4.45% |
| Novo Holdings A/S | 3,327,768 | $85,324,000 | 4.07% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $911,000 | 2.72% |
| Quantedge Capital Pte Ltd | 243,712 | $6,249,000 | 1.93% |
| S&T BANK/PA | 349,456 | $8,960,000 | 1.73% |
| Birchview Capital, LP | 50,000 | $1,282,000 | 0.90% |
| Bridge City Capital, LLC | 61,254 | $1,571,000 | 0.86% |
| FAS Wealth Partners, Inc. | 299,576 | $7,681,000 | 0.85% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $13,075,000 | 0.76% |